Beckman Coulter has brought out the PA 800 plus Pharmaceutical Analysis System, a next-generation capillary electrophoresis (CE) platform.
The system, which was designed in collaboration with biopharmaceutical development and QC groups, provides users with a characterisation platform that integrates quantitative, qualitative and automated solutions for analysis of protein purity, charge isoform distribution and glycan structure.
An emphasis on the portability of assays between laboratories enhances system utility in multi-user/multi-instrument facilities.
Mark Lies, PA 800 plus product manager, said: 'The PA 800 plus automated environment facilitates precise quantitation in SDS-gel analysis, iso-electric focusing and glycan characterisation of monoclonal antibodies and other therapeutic proteins.
'Capillary electrophoresis is rapidly becoming the gold standard for these applications.
'This new platform will significantly increase operational efficiency for biotherapeutic characterisation in development and QC.' New PA 800 plus software quickly guides users from set-up through operation in routine applications.
Intuitive navigation is achieved through visual cues and insightful help messages.
Innovations in system-design ensure dependable operation and durability, with minimal maintenance requirements.
Modular ultraviolet, photodiode array and solid-state laser-induced fluorescence detectors are readily interchanged, allowing a variety of applications to be run on an instrument with a compact footprint.
